Showing results (411-420 of 984) with videos related to

Sort By:
Pageof 99
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemiaRena M Conti, William V Padula, Russell V Becker, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Clinical pharmacology of intraperitoneal cisplatin-based chemotherapyM Conti, U De Giorgi, V Tazzari, et al.
Molecular Endocrinology (Baltimore, Md.)|September 1, 1996
The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptorsB Hirsch, M Kudo, F Naro, et al.
Lupus|October 18, 2000
Erythema nodosum associated with antiphospholipid antibodies: a report of three casesL Nekhlyudov, M Gradzka, A M Conti-Kelly, et al.
Oncology|January 1, 1987
Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesisC F Pollera, E M Conti, A De Nigris, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
Follicle-stimulating hormone induces transient expression of the protooncogene c-fos in primary Sertoli cell culturesS H Hall, D R Joseph, F S French, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 1988
The gene structure of rat androgen-binding protein: identification of potential regulatory deoxyribonucleic acid elements of a follicle-stimulating hormone-regulated proteinD R Joseph, S H Hall, M Conti, et al.
The Milbank Quarterly|January 29, 2024
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed LiteratureTimothy W Levengood, Rena M Conti, Sean Cahill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cellsWei Wang, Norma S Ostlie, Bianca M Conti-Fine, et al.
Minerva Medica|May 1, 1989
[Nonpsychotic involutional inhibited depressions and psycho-organic deteriorations: treatment with Viloxazine and piracetam]A Borromei, R Caramelli, M Conti, et al.
Pageof 99